Researchers Seek Out Local Foundations When NIH Rejects Their Grant Proposals

For countless scientists, it's a vicious cycle. They need funds to turn their exploratory research into more viable projects, yet the National Institutes of Health tends to reject grant applications for investigations that are still in the early stages. So what's a researcher to do? The answer may be to turn away from the large, national agencies and toward small, local ones, a prime example of which is the Bryn Mawr, Pa.-based W.W. Smith Charitable Trust. George Preti, organic chemist and sen

Written byBruce Silver
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

For countless scientists, it's a vicious cycle. They need funds to turn their exploratory research into more viable projects, yet the National Institutes of Health tends to reject grant applications for investigations that are still in the early stages. So what's a researcher to do? The answer may be to turn away from the large, national agencies and toward small, local ones, a prime example of which is the Bryn Mawr, Pa.-based W.W. Smith Charitable Trust.

George Preti, organic chemist and senior researcher at the Monell Chemical Senses Center in Philadelphia, was faced with this problem in 1987, when NIH declined to fund his search for a new technique for the early detection of cancer. Like many scientists seeking support in the early stages of research, he did not have sufficient data to qualify for an NIH grant. To get the money to broaden his studies and generate the kind ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery